Colgate-Palmolive Company (CL): Price and Financial Metrics
Colgate-Palmolive Company (CL)
Today's Latest Price: $75.80 USD
Updated Sep 25 11:37am
Add CL to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 34 in Consumer Goods
See all "A" rated Strong Buy stocks
CL Stock Summary
- Colgate Palmolive Co's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 99.52% of US listed stocks.
- CL's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of merely 0.02% of US stocks.
- The volatility of Colgate Palmolive Co's share price is greater than that of merely 0.65% US stocks with at least 200 days of trading history.
- Stocks with similar financial metrics, market capitalization, and price volatility to Colgate Palmolive Co are KMB, LNG, TCO, AMC, and JAKK.
- Visit CL's SEC page to see the company's official filings. To visit the company's web site, go to www.colgatepalmolive.com.
CL Stock Price Chart Technical Analysis Charts
CL Price/Volume Stats
| Current price | $75.80 | 52-week high | $80.10 |
| Prev. close | $75.76 | 52-week low | $58.49 |
| Day low | $75.33 | Volume | 952,484 |
| Day high | $75.86 | Avg. volume | 4,408,768 |
| 50-day MA | $76.73 | Dividend yield | 2.32% |
| 200-day MA | $72.28 | Market Cap | 64.99B |
Colgate-Palmolive Company (CL) Company Bio
Colgate-Palmolive manufactures and markets consumer products worldwide. It operates in two segments: Oral, Personal and Home Care; and Pet Nutrition. The company was founded in 1806 and is based in New York, New York.
CL Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $75.80 | $43.07 | -43% |
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Colgate Palmolive Co. To summarize, we found that Colgate Palmolive Co ranked in the 31th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. The most interesting components of our discounted cash flow analysis for Colgate Palmolive Co ended up being:
- The company's debt burden, as measured by earnings divided by interest payments, is 24.83; that's higher than 87.33% of US stocks in the Consumer Defensive sector that have positive free cash flow.
- The business' balance sheet reveals debt to be 10% of the company's capital (with equity being the remaining amount). Approximately merely 22.54% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
- CL's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 36.85% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -44% |
| 1% | -44% |
| 2% | -43% |
| 3% | -43% |
| 4% | -42% |
| 5% | -41% |
For other companies in the Consumer Defensive that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as CL, try VLGEA, YEWB, UVV, K, and STKL.
Loading social stream, please wait...